Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort

Abstract Background For clinical implementation of Alzheimer’s disease (AD) blood-based biomarkers (BBMs), knowledge of short-term variability, is crucial to ensure safe and correct biomarker interpretation, i.e., to capture changes or treatment effects that lie beyond that of expected short-term va...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Frederikke Kragh Clemmensen, Mathias Holsey Gramkow, Anja Hviid Simonsen, Nicholas J. Ashton, Hanna Huber, Kaj Blennow, Henrik Zetterberg, Gunhild Waldemar, Steen Gregers Hasselbalch, Kristian Steen Frederiksen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2025-01-01
Σειρά:	Alzheimer’s Research & Therapy
Θέματα:	Alzheimer’s disease biomarkers Blood-based biomarkers Memory clinic cohort Short-term variability Intra- and Inter-individual variability, Reference change value (RCV), Plasma Aβ42/Aβ40 ratio, Phosphorylated tau (p-tau), Neurofilament light (NfL), Glial fibrillary acidic protein (GFAP)
Διαθέσιμο Online:	https://doi.org/10.1186/s13195-024-01658-7
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!